In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Medicis to license dermatological products from HMR

Executive Summary

Medicis Pharmaceutical Corp. has reached a definitive agreement to license in the US--with an option to purchase--marketed topical dermatological products Loprox (ciclopirox olamine), and anti-fungal; Topicort (desoximetasone), an anti-inflammatory; and A/T/S(erythromycin) for acne, from Hoechst Marion Roussel.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • Marketing (Licensing)
    • Reverse Licensing

Related Companies